> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
By Malcolm Stacey | Thursday 8 December 2016
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Shiners. The decaying share value of Advanced Oncotherapy (AVO) after and during inquiries by Uncle Tom will have left a fair few of us nursing losses. My own shortfall after selling my shares is not to be sniffed at.
However, I want to make a suggestion here that your experience with Advanced should not leave you with feelings of self-recrimination. There is also always a bigger risk than most shares in investing in medical pioneers.
There are huge costs in research and development, which must be followed by testing much more rigorous than any other kind of scientific scrutiny. Delays are common - and delays cost a lot of mazuma.
But what would happen if nobody invested in medical pioneering? A lot of you reading this would not be alive today. I’m sorry if this puts you off your sarnie, but it’s probably true.
So if you are kicking yourself for investing in Advanced in the first place, you should stop. When I initially featured the share, there was a good chance that the proton beam machines the company is developing would solve a very severe problem, zapping cancer cells without damaging nearby healthy cells.
And if that aim in mind, what a wonderful thing your investment would have been. Two people have made prayer requests at my church recently. Both ask God to cure brain tumours - one from a distraught husband for his wife, Janice, and one for another Tom, the father of two young children.
Maybe Advanced Oncotherapy machines could have helped in tragic cases like this. It’s just that without a group of customers on the horizon, the shares is, in my view, no longer a promising investment.
There is a chance that a bigger company may ride forth in a white knight venture, though I wouldn’t bet on it.
The only point I want to put across is that medical pioneering companies are important if we want to fight the growing threats of cancer, dementia and super bugs, to name just a few. I for one will not be put off investing in them from time to time - but only if my researches show promise.
And now please join me in the Punter’s Return.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen